Paul M. Silva, SVP & Controller at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 151 shares at $287.00 ($43K) on 2020-05-15, disclosed to the SEC on 2020-05-19.
Scheduled sale ($43k) by SVP & Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $275.71 | 10 | $3K | 6.4% |
| 2 | $279.89 | 30 | $8K | 19.6% |
| 3 | $281.81 | 20 | $6K | 13.1% |
| 4 | $282.85 | 10 | $3K | 6.6% |
| 5 | $285.51 | 20 | $6K | 13.3% |
| 6 | $287.00 | 14 |
| $4K |
| 9.4% |
| 7 | $288.04 | 47 | $14K | 31.6% |
| Total | $284.00 avg | 151 | $43K | 100% |
| Filing → |
| VRTX | SELL | 2021-02-19 | $1.8M | — | Filing → |
| VRTX | SELL | 2021-02-16 | $586K | — | Filing → |
| VRTX | SELL | 2020-08-10 | $564K | — | Filing → |